全文获取类型
收费全文 | 8056篇 |
免费 | 386篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 214篇 |
妇产科学 | 34篇 |
基础医学 | 993篇 |
口腔科学 | 111篇 |
临床医学 | 464篇 |
内科学 | 1968篇 |
皮肤病学 | 173篇 |
神经病学 | 619篇 |
特种医学 | 192篇 |
外科学 | 1523篇 |
综合类 | 32篇 |
预防医学 | 221篇 |
眼科学 | 295篇 |
药学 | 620篇 |
中国医学 | 3篇 |
肿瘤学 | 917篇 |
出版年
2022年 | 74篇 |
2021年 | 104篇 |
2020年 | 76篇 |
2019年 | 90篇 |
2018年 | 137篇 |
2017年 | 120篇 |
2016年 | 141篇 |
2015年 | 158篇 |
2014年 | 205篇 |
2013年 | 253篇 |
2012年 | 380篇 |
2011年 | 437篇 |
2010年 | 248篇 |
2009年 | 200篇 |
2008年 | 347篇 |
2007年 | 394篇 |
2006年 | 417篇 |
2005年 | 427篇 |
2004年 | 402篇 |
2003年 | 408篇 |
2002年 | 430篇 |
2001年 | 221篇 |
2000年 | 240篇 |
1999年 | 244篇 |
1998年 | 103篇 |
1997年 | 94篇 |
1996年 | 89篇 |
1995年 | 78篇 |
1994年 | 81篇 |
1993年 | 82篇 |
1992年 | 162篇 |
1991年 | 148篇 |
1990年 | 142篇 |
1989年 | 129篇 |
1988年 | 128篇 |
1987年 | 102篇 |
1986年 | 124篇 |
1985年 | 122篇 |
1984年 | 69篇 |
1983年 | 60篇 |
1982年 | 43篇 |
1981年 | 31篇 |
1979年 | 45篇 |
1977年 | 40篇 |
1974年 | 40篇 |
1973年 | 34篇 |
1972年 | 34篇 |
1969年 | 33篇 |
1967年 | 37篇 |
1966年 | 33篇 |
排序方式: 共有8473条查询结果,搜索用时 31 毫秒
191.
Tatsuya Kondo Sayaka Kitano Nobukazu Miyakawa Takuro Watanabe Rieko Goto Miki Sato Satoko Hanatani Masaji Sakaguchi Motoyuki Igata Junji Kawashima Hiroyuki Motoshima Takeshi Matsumura Eiichi Araki 《Internal medicine (Tokyo, Japan)》2021,60(9):1433
The gastrointestinal tract is considered an important endocrine organ for controlling glucose homeostasis via the production of incretins. A 21-year-old man emergently underwent total colectomy due to severe ulcerative colitis, and overt diabetes became evident. Weekly administration of a glucagon-like peptide (GLP)-1 receptor agonist (RA) dramatically improved his glucose control. Levels of GLP-1 or gastric inhibitory polypeptide (GIP) were low at the baseline in the duodenum and serum of the patient. After 11 months of GLP-1RA treatment, his HbA1c worsened again, and intensive insulin therapy was necessary to control his glucose levels. Our report may explain the significance of residual incretin for maintaining the pancreatic β-cell function. 相似文献
192.
Suga N Takada H Nomura A Ohga S Ishii E Ihara K Ohshima K Hara T 《British journal of haematology》2002,116(2):346-349
The perforin gene was analysed in 15 Japanese patients with primary haemophagocytic lymphohistiocytosis (HLH). Perforin gene defects were found in two out of eight patients with familial HLH (FHL), and one out of seven without affected siblings. Four novel mutations were identified. Compound heterozygous mutations (one FHL and one sporadic HLH) and only one allele mutation (one FHL) were defined. Flow cytometry revealed no perforin expression in CD8+ or CD56+ cells from a surviving patient with a mutation. The frequency of mutation was at least 20% of FHL in Japan. Flow cytometry for intracellular perforin may be useful for the screening of FHL2. 相似文献
193.
M. Kaneko S. Nishinarita N. Kitamura Y. Tomita Y. Matsukawa S. Sawada T. Horie N. Tanaka Y. Arakawa 《Modern rheumatology / the Japan Rheumatism Association》2002,12(1):10-17
We studied isotype-specific rheumatoid factors (RFs) to clarify their significance in rheumatoid arthritis (RA) and to verify
the difference in RF isotypes between RA and chronic liver diseases (CLD). Isotype-specific RFs in RA and in CLD were measured
by enzyme-linked immunosorbent assay (ELISA). Most sera (n = 51, 94.1%) from RA patients contained some kind of RF isotypes (92.1% for IgM RF, 76.4% for IgG RF, and 43.1% for IgA RF),
and seronegative RA by ELISA was seen in only 11.8% (n = 6). The most characteristic combination of RF isotypes in active RA was IgG, IgA, and IgM. This combination of RF isotypes
changed to IgG plus IgM, according to the diminution of RA activity; then, we found only IgM RF in inactive RA. The titers
of each RF isotype also decreased in parallel with the activity of RA. IgA RF seemed to be the most sensitive factor for evaluating
the activity of RA. In CLD, almost the same high frequency (n = 49, 89.8% for IgM RF, 59.2% for IgG RF), with the same titer levels seen in RA, was observed. On the other hand, IgA RF
was significantly lower in frequency (n = 9, 18.4%) and in titer, compared with the finding in RA. Surprisingly, even in CLD, true seronegativity by ELISA was also
found in very few patients (n = 4, 8.1%). In CLD, positive RFs detected by agglutination assay were seen more often in chronic hepatitis than in liver
cirrhosis. In RA patients, significant associations of IgA RF and the serum concentration of IgA, and IgG RF and the serum
concentration of IgG, were observed. On the other hand, in CLD patients, significant associations of IgG RF and the serum
IgG concentration, and of IgM RF and the serum IgM concentration, were observed. These results indicated that IgA RF in active
RA is the most characteristic RF isotype distinguishing it from other nonrheumatic diseases, as well as from inactive RA.
RF isotypes reflected the background polyclonal B-cell activation in different manners in both diseases. In CLD, RF isotypes
seemed to be disease-related immunological disorders reflecting disease progression.
Received: February 17, 2000 / Accepted: July 5, 2001 相似文献
194.
A Japanese Family with Two Sisters Apparently Homozygous for Mk 总被引:1,自引:0,他引:1
Y. Okubo G.L. Daniels S.F. Parsons D.J. Anstee H. Yamaguchi T. Tomita and T. Seno 《Vox sanguinis》1988,54(2):107-111
Two Japanese sisters with consanguineous parents have M-N- En(a-) Wr(a-b-) S-s-U- red cells and are therefore apparently homozygous for Mk; the third reported family with members of this genotype. The serum of the proposita (ORCMK) contained anti-EnaTS, anti-EnaFR and possibly anti-Wrb, whereas the serum of her MkMk sister contained no atypical antibodies. Total absence of sialoglycoproteins alpha and delta from red cell membranes of an Mk homozygote was demonstrated by lactoperoxidase-catalysed radioiodination of accessible tyrosine residues with subsequent SDS polyacrylamide gel electrophoresis and autoradiography, and by use of a monoclonal antibody directed at the cytoplasmic portion of alpha-sialoglycoprotein. 相似文献
195.
Ohno J Watanabe E Toyama J Kawamura T Ohno M Kodama I 《International journal of cardiology》2004,93(2-3):263-268
BACKGROUND: Recent clinical trials suggest that the mortality in high-risk patients with ischemic heart disease can be significantly reduced with the use of implantable cardioverter-defibrillator (ICD). Given the high cost and invasiveness of the procedure, it is important to apply it to the patients after myocardial infarction (MI) highly susceptible to sudden arrhythmic death. OBJECTIVE: The purpose of this study was to assess clinical predictors of mortality in post-MI patients in Japan. METHODS AND RESULTS: In 495 consecutive MI survivors, 350 (71%) received acute-reperfusion therapy, whereas 145 (29%) did not. Nonsustained ventricular tachycardia (NSVT) was present in 136 patients (28%) in 24-h ambulatory ECGs at 7+/-6 in-hospital days. Left ventricular dysfunction (LVEF< or =35%) was present in 20/347 patients (5.7%) at 13+/-8 days. Forty-eight patients (9.7%) died during the follow-up period (48+/-13 months); 23 from cardiac and 25 from noncardiac causes. Kaplan-Meier survival analyses showed that mortality rates were higher among patients who were > or =70 years old (log-rank test, P<0.0001); had heart failure at admission (Killip scale> or =2, P=0.001); did not receive acute-reperfusion (P=0.004); and had left ventricular dysfunction with LVEF< or =35% (P=0.02). The presence of NSVT was a significant predictor of death (P=0.036) only in the patients who did not receive acute-reperfusion. Multivariate Cox regression analysis revealed that an independent predictor of total mortality was an age> or =70 (odds ratio, 1.06; 95% confidence interval, 1.01-1.11; P<0.00001). CONCLUSIONS: High-risk patients after acute MI can be identified on the basis of age, ventricular dysfunction, heart failure and acute-reperfusion therapy. The presence of NSVT before discharge has a prognostic value only in the patients without acute-reperfusion. 相似文献
196.
p53 point mutations in primary human gastric carcinomas 总被引:12,自引:0,他引:12
Hiroshi Yokozaki Hiroki Kuniyasu Yasuhiko Kitadai Kenji Nishimura Hiroko Todo Ayşe Ayhan Wataru Yasui Hisao Ito Eiichi Tahara 《Journal of cancer research and clinical oncology》1992,119(2):67-70
Summary p53 point mutations in primary gastric carcinomas were analyzed by performing cDNA deoxynucleotide sequencing of the gene. Out of 16,9 (56.3%) primary gastric carcinoma cases, including early cancer, showed one or more p53 point mutations in their open-reading frame, and 4 out of 9 cases had a p53 point mutation within highly conserved domains. The characteristics of the p53 mutation spectrum observed in primary tumors were (a) frequent mutation at an A:T pair (50%, 7 out of 14 mutations), (b) high transversion incidence (29%, 4 out of 14 mutations), (c) no transition at CpG, and (d) no G:C to T:A transversion. Our results suggest that p53 mutation is a common event in gastric carcinoma occurring from the early stage of progression with its specific mutation spectrum.Abbreviation PCR-SSCP
polymerase chain reaction single-strand conformation polymorphism 相似文献
197.
AIMS: We recently demonstrated that aldosterone induces a non-genomic vasoconstrictor effect on rat coronary arterioles and that this effect was blocked by angiotensin II type 1 receptor (AT1) blockers. Intracellular transglutaminase enhances AT1 signalling by cross-linking AT1 homodimers. The purpose of this study was to confirm the AT1-dependency of the vasoconstrictor effect of aldosterone using AT1a knockout (AT1aKO) mice and to investigate the role of intracellular transglutaminase and AT1 dimerization in this effect. METHODS AND RESULTS: The mesenteric arterioles (60-160 microm) were isolated from C57BL/6J (wild-type, WT) and AT1aKO mice, and the internal diameter was measured by video microscopy. Aldosterone (10(-13) to 10(-6) M), but not hydrocortisone, produced a dose-dependent vasoconstriction in WT mice; the maximal diameter change was -8.6 +/- 0.3% from the baseline (P < 0.001). This vasoconstrictor effect was unaffected by the mineralocorticoid receptor antagonist spironolactone or eplerenone, the AT2 antagonist PD123319, the glucocorticoid receptor antagonist RU486, or endothelium denudation. Aldosterone's vasoconstrictor effect was negligible in AT1aKO mice. The AT1 blockers valsartan or candesartan suppressed aldosterone-induced vasoconstriction in WT mice. The transglutaminase inhibitors cystamine and monodansyl cadaverine also suppressed the vasoconstrictor effect of aldosterone, without affecting the vasoconstrictor effect of angiotensin II in WT mice. AT1 dimer protein levels were increased in WT mesenteric arterioles treated with 10(-7) M aldosterone, and the transglutaminase inhibitor and AT1 blocker blocked this aldosterone-induced formation of AT1 dimer. Treatment with 10(-7) M aldosterone for 10 min increased the transglutaminase activity by 2.5 +/- 0.2-fold in cultured vascular smooth muscle cells and by 1.2 +/- 0.1-fold in the mesenteric arterioles. These increases were abolished by transglutaminase inhibitors. CONCLUSION: Aldosterone produces a non-genomic, endothelium-independent vasoconstrictor effect by enhancing intracellular transglutaminase activity and presumably inducing AT1 dimer formation in mesenteric arterioles. 相似文献
198.
199.
Matsumoto K Morishita R Tomita N Moriguchi A Komai N Aoki M Matsumoto K Nakamura T Higaki J Ogihara T 《Heart and vessels》2003,18(1):18-25
Hepatocyte growth factor (HGF) is a unique growth factor with many protective functions. Previously, we demonstrated that
HGF stimulated growth of endothelial cells without replication of vascular smooth muscle cells (VSMC) and that angiotensin
(Ang) II significantly decreased local HGF production in VSMC. Moreover, we also reported that high glucose significantly
decreased local vascular HGF production. Therefore, we examined effects of Ang II blockade on vascular HGF expression and
endothelial injury in diabetic hypertensive rats. An angiotensin-converting enzyme inhibitor (quinapril) and an Ang II type
1 receptor antagonist (GA-0113) or vehicle was administrated to diabetic spontaneously hypertensive rats (SHR-DM), in whom
diabetes was induced by streptozotocin. Endothelial function was evaluated by the vasodilator response to acetylcholine, and
the expression of vascular HGF and its receptor, c-met, was examined by immunohistochemistry. Both quinapril and GA-0113 significantly
improved the vasodilator response to acetylcholine (P < 0.01), while vehicle did not as compared to untreated normotensive Wistar-Kyoto rats (WKY). We next examined the effects
of Ang II blockade on vascular HGF expression in SHR-DM. Importantly, the vascular HGF level was markedly decreased in SHR-DM
as compared to WKY, while Ang II blockade by quinapril or GA-0113 significantly increased positive staining for HGF in SHR-DM.
Similarly, staining of its specific receptor, c-met, was less in the blood vessels of SHR-DM as compared to WKY. In contrast,
Ang II blockade also significantly increased c-met production in SHR-DM. The present data demonstrated the improvement of
endothelial dysfunction by Ang II blockade in SHR-SM, accompanied by an increase in vascular HGF and c-met.
Received: June 7, 2002 / Accepted: September 21, 2002
Acknowledgments We wish to thank Rie Kosai and Keiko Yamaguchi for their excellent technical assistance. This work was partially supported
by grants from the Japan Health Sciences Foundation, a Grant-in-Aid from The Ministry of Public Health and Welfare, a Grant-in-Aid
for the Development of Innovative Technology, a Grant-in-Aid from Japan Promotion of Science, and through Special Coordination
Funds of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government.
Correspondence to N. Tomita 相似文献
200.
Ito E Takahashi A Yamamoto H Kuzuhara S Uchiyama S Nakajima M;Tokai Panaldine Aspirin Long-Term Study 《Internal medicine (Tokyo, Japan)》2003,42(9):793-799
OBJECTIVE: To compare the efficacy and safety of two antiplatelet regimens, ticlopidine alone (200 mg daily) and ticlopidine (100 mg daily) plus aspirin (81 mg daily), in patients with ischemic stroke from the Tokai district of Japan. METHODS: A randomized comparative study was performed from April 1992 until December 1995, with follow-up for an average of 1.59 years (maximum: 3 years). Statistical analysis was done on 270 eligible patients (138 treated with ticlopidine alone and 132 treated with ticlopidine plus aspirin). PATIENTS: A total of 276 patients who had cerebral infarction within the previous 1 to 6 months, or one or more transient ischemic attacks within the previous 3 months. RESULTS: The incidence of ischemic and hemorrhagic stroke, myocardial infarction, and other vascular events was 10.1% (n = 14) in the ticlopidine group and 9.8% (n = 13) in the ticlopidine plus aspirin group, showing no significant difference (p = 0.933). There was also no significant difference in the event-free rate between the two groups (p = 0.5003, Kaplan-Meier analysis and log-rank test). Regarding serious adverse reactions, neutropenia occurred in one patient from the ticlopidine group, while gastric ulcer and thrombocytopenia occurred in one patient each from the ticlopidine plus aspirin group. CONCLUSION: We conclude that both antiplatelet regimens are comparable in efficacy and safety for preventing the recurrence of ischemic stroke. 相似文献